Personalized Combination Therapy
Personalized Combination Therapy is a therapeutic strategy that belongs to the class of combination therapies and is distinguished by its systematic design and application of multiple repurposed drug regimens tailored to individual patient characteristics, such as genomic profiles, disease subtypes, and resistance mechanisms, to optimize efficacy and minimize adverse effects.
37
Publications
1.9K
Citations
353
Authors
163
Institutions
Publications per year
2017–2026
24
37
Independent Drug Action in Combination Therapy: Implications for Precision Oncology
Cancer Discovery · 2022 · 301 citations · Full text
Medicine, Oncology, Pharmacology +17
In silico drug combination discovery for personalized cancer therapy
Minji Jeon, Sunkyu Kim, Sung‐Joon Park et al. · BMC Systems Biology · 2018 · 83 citations · Full text
1–5 of 37
353
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 353
163
Moffitt Cancer Center
Tampa, United States
3 h-index
20 publications
707 citations
Heidelberg University
Heidelberg, Germany
2 h-index
17 publications
237 citations
The Barbara Ann Karmanos Cancer Institute
Detroit, United States
2 h-index
3 publications
67 citations
University of California San Diego
San Diego, United States
2 h-index
11 publications
6.5K citations
Wayne State University
Detroit, United States
2 h-index
2 publications
55 citations
National University of Singapore
Singapore, Singapore
2 h-index
13 publications
386 citations
The University of Texas MD Anderson Cancer Center
Houston, United States
2 h-index
18 publications
1.6K citations
Georgetown University
Washington, United States
2 h-index
2 publications
32 citations
1–8 of 163
2 publications · 31 citations
2
h-index
2 publications · 738 citations
2
h-index
2 publications · 56 citations
2
h-index
2 publications · 113 citations
2
h-index
1 publications · 12 citations
1
h-index
1–5